大麻素受体激动剂 WIN 55,212-2 对高架十字迷宫中遗传性癫痫发作模型的焦虑样行为和运动的影响。
The effect of cannabinoid receptor agonist WIN 55,212-2 on anxiety-like behavior and locomotion in a genetic model of absence seizures in the elevated plus-maze.
机构信息
Laboratory of Neurophysiology, Department of Physiology and Biochemistry, Faculty of Medicine and Surgery, University of Malta, Msida, Malta.
Laboratory of Behavioral Physiology, Human Physiology Section "Giuseppe Pagano", Department of Biomedicine, Neuroscience and Advanced Diagnosistics (BIND), University of Palermo, Palermo, Italy.
出版信息
CNS Neurosci Ther. 2022 Aug;28(8):1268-1270. doi: 10.1111/cns.13848. Epub 2022 Apr 26.
Abstract
GAERS and NEC rats were treated with cannabinoid 1/2 receptor agonist WIN 55,212-2 2 mg/kg and tested on the Elevated Plus-Maze.
摘要
GAERS 和 NEC 大鼠接受大麻素 1/2 受体激动剂 WIN 55,212-2（2 毫克/千克）治疗，并在高架十字迷宫上进行测试。
相似文献
1
The effect of cannabinoid receptor agonist WIN 55,212-2 on anxiety-like behavior and locomotion in a genetic model of absence seizures in the elevated plus-maze.
CNS Neurosci Ther. 2022 Aug;28(8):1268-1270. doi: 10.1111/cns.13848. Epub 2022 Apr 26.
2
Increased sensitivity of adolescent spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder, to the locomotor stimulation induced by the cannabinoid receptor agonist WIN 55,212-2.
Eur J Pharmacol. 2007 Jun 1;563(1-3):141-8. doi: 10.1016/j.ejphar.2007.02.013. Epub 2007 Feb 17.
3
Cannabinoid system of the lateral septum in the modulation of anxiety-like behaviors in rats.
Arch Iran Med. 2013 Dec;16(12):711-6.
4
Somatic and anxiety-like behaviors in male and female rats during withdrawal from the non-selective cannabinoid agonist WIN 55,212-2.
Pharmacol Biochem Behav. 2024 Mar;236:173707. doi: 10.1016/j.pbb.2024.173707. Epub 2024 Jan 18.
5
Effects of WIN 55,212-2 mesylate (a synthetic cannabinoid) on the protective action of clonazepam, ethosuximide, phenobarbital and valproate against pentylenetetrazole-induced clonic seizures in mice.
Prog Neuropsychopharmacol Biol Psychiatry. 2011 Dec 1;35(8):1870-6. doi: 10.1016/j.pnpbp.2011.07.001. Epub 2011 Jul 18.
6
Effects of WIN 55,212-2 (a synthetic cannabinoid CB1 and CB2 receptor agonist) on the anticonvulsant activity of various novel antiepileptic drugs against 6 Hz-induced psychomotor seizures in mice.
Pharmacol Biochem Behav. 2015 Mar;130:53-8. doi: 10.1016/j.pbb.2015.01.003. Epub 2015 Jan 13.
7
A quantitative and T-pattern analysis of anxiety-like behavior in male GAERS, NEC, and Wistar rats bred under the same conditions, against a commercially available Wistar control group in the hole board and elevated plus maze tests.
CNS Neurosci Ther. 2024 Mar;30(3):e14443. doi: 10.1111/cns.14443. Epub 2023 Sep 2.
8
CB1 agonists, locally applied to the cortico-thalamic circuit of rats with genetic absence epilepsy, reduce epileptic manifestations.
Epilepsy Res. 2013 Sep;106(1-2):74-82. doi: 10.1016/j.eplepsyres.2013.06.004. Epub 2013 Jul 13.
9
Cannabinoid type 1 receptor ligands WIN 55,212-2 and AM 251 alter anxiety-like behaviors of marmoset monkeys in an open-field test.
Behav Brain Res. 2013 Mar 1;240:91-4. doi: 10.1016/j.bbr.2012.11.018. Epub 2012 Nov 23.
10
Post-status epilepticus treatment with the cannabinoid agonist WIN 55,212-2 prevents chronic epileptic hippocampal damage in rats.
Neurobiol Dis. 2015 Jan;73:356-65. doi: 10.1016/j.nbd.2014.10.018. Epub 2014 Oct 30.
引用本文的文献
1
Impairment of Spatial Working Memory but Preservation of Recognition Memory in Female Rats with Spontaneous Absence Seizures.
Neurochem Res. 2025 Jul 17;50(4):236. doi: 10.1007/s11064-025-04485-w.
2
Dysregulation of the Cannabinoid System in Childhood Epilepsy: From Mechanisms to Therapy.
Int J Mol Sci. 2025 Jun 27;26(13):6234. doi: 10.3390/ijms26136234.
3
A quantitative and T-pattern analysis of anxiety-like behavior in male GAERS, NEC, and Wistar rats bred under the same conditions, against a commercially available Wistar control group in the hole board and elevated plus maze tests.
CNS Neurosci Ther. 2024 Mar;30(3):e14443. doi: 10.1111/cns.14443. Epub 2023 Sep 2.
4
Chronic exposure to a synthetic cannabinoid alters cerebral brain metabolism and causes long-lasting behavioral deficits in adult mice.
J Neural Transm (Vienna). 2023 Aug;130(8):1013-1027. doi: 10.1007/s00702-023-02607-8. Epub 2023 Feb 28.
本文引用的文献
1
Positive allosteric modulation of type 1 cannabinoid receptors reduces spike-and-wave discharges in Genetic Absence Epilepsy Rats from Strasbourg.
Neuropharmacology. 2021 Jun 1;190:108553. doi: 10.1016/j.neuropharm.2021.108553. Epub 2021 Apr 9.
2
Absence seizures and their relationship to depression and anxiety: Evidence for bidirectionality.
Epilepsia. 2021 May;62(5):1041-1056. doi: 10.1111/epi.16862. Epub 2021 Mar 10.
3
Endocannabinoid-serotonin systems interaction in health and disease.
Prog Brain Res. 2021;259:83-134. doi: 10.1016/bs.pbr.2021.01.003. Epub 2021 Jan 22.
4
Clinical and experimental insight into pathophysiology, comorbidity and therapy of absence seizures.
Brain. 2020 Aug 1;143(8):2341-2368. doi: 10.1093/brain/awaa072.
5
Altered SWD stopping mechanism in WAG/Rij rats subchronically treated with the cannabinoid agonist R(+)WIN55,212-2.
Epilepsy Behav. 2020 Jan;102:106722. doi: 10.1016/j.yebeh.2019.106722. Epub 2019 Dec 25.
6
Role for serotonin2A (5-HT2A) and 2C (5-HT2C) receptors in experimental absence seizures.
Neuropharmacology. 2016 Sep;108:292-304. doi: 10.1016/j.neuropharm.2016.04.016. Epub 2016 Apr 13.
7
The Genetic Absence Epilepsy Rats from Strasbourg model of absence epilepsy exhibits alterations in fear conditioning and latent inhibition consistent with psychiatric comorbidities in humans.
Eur J Neurosci. 2016 Jan;43(1):25-40. doi: 10.1111/ejn.13110. Epub 2015 Nov 25.
8
Anxiety and locomotion in Genetic Absence Epilepsy Rats from Strasbourg (GAERS): inclusion of Wistar rats as a second control.
Epilepsia. 2014 Sep;55(9):1460-8. doi: 10.1111/epi.12738. Epub 2014 Jul 24.
9
A genetic epilepsy rat model displays endophenotypes of psychosis.
Neurobiol Dis. 2010 Jul;39(1):116-25. doi: 10.1016/j.nbd.2010.02.001. Epub 2010 Feb 11.
10
WAG/Rij rats show a reduced expression of CB₁ receptors in thalamic nuclei and respond to the CB₁ receptor agonist, R(+)WIN55,212-2, with a reduced incidence of spike-wave discharges.
Epilepsia. 2010 Aug;51(8):1511-21. doi: 10.1111/j.1528-1167.2009.02510.x. Epub 2010 Feb 3.
Zotero 插件